Lymphatica Medtech: Funding, Investors & Team (Sep 2026)
Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium.
Lymphatica Medtech has raised $19.7M across 1 funding round on record, the most recent a Series B of $19.7M announced in Oct 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lymphatica Medtech Company Profile and Key Stats
Latest funding round on record: Oct 2024.
Lymphatica Medtech Funding Rounds
Lymphatica Medtech Founders and Leadership Team
No contact details are on record for this team yet.
Lymphatica Medtech Funding Compared to Other Biotechnology Startups
Lymphatica Medtech's latest round of $19.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lymphatica Medtech in Biotechnology and Ecublens
Companies Similar to Lymphatica Medtech
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Lymphatica Medtech Funding FAQs
What does Lymphatica Medtech do?
Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium.
How much funding has Lymphatica Medtech raised?
Lymphatica Medtech has raised $19.7M across 1 round on record. The most recent is a Series B of $19.7M announced in Oct 2024.
When did Lymphatica Medtech last raise funding?
Lymphatica Medtech's most recent funding round on record is a Series B of $19.7M, announced in Oct 2024.
Who founded Lymphatica Medtech?
FundedIQ lists Valentina Triacca (Founder) at Lymphatica Medtech.
Where is Lymphatica Medtech headquartered?
Lymphatica Medtech is based in Ecublens, Vaud, Switzerland.
How many employees does Lymphatica Medtech have?
Lymphatica Medtech is in the 11-50 employee band.
How does Lymphatica Medtech's funding compare to other Biotechnology startups?
Lymphatica Medtech's latest round of $19.7M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Lymphatica Medtech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lymphatica Medtech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.